A fully integrated microfluidic platform for highly sensitive analysis of immunochemical parameters.

We present a novel fully integrated centrifugal microfluidic platform for highly sensitive immunoassays in point-of-care settings. The platform consists of a disposable cartridge containing structures for assay processing, a porous membrane and all dried reagents required for the analysis. Additionally, a blister containing a washing buffer is connected to a new aliquoting structure enabling the serial aliquoting of washing buffer for repetitive bound-free separation steps.

A new immunochemistry platform for a guideline-compliant cardiac troponin T assay at the point of care: proof of principle.

Background: A multitude of troponin assays for the point-of-care (POC) have been developed showing a lack of analytical sensitivity and precision. We present a new platform solution for the high-sensitivity detection of cardiac troponin T (cTnT) in a 30 μL whole blood sample with a turnaround time of 11 min.

Methods: The immunoassay was completely run in a ready-to-use plastic disposable, a centrifugal microfluidic disc with fully integrated reagents.

Model fluids representing aqueous in-vitro diagnostic reagents for the development of dispensing systems.

Analyzers for in-vitro diagnostic (IVD) testing facilitate the determination of medical information from biological samples. To reach a high quality, the detection reagents have to be dispensed with a high degree of precision and accuracy. A technology change from conventional pipetting systems to contact-free dispensers provides the opportunity to reduce carry-over and handle reagents in the microliter range.

Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood.

A new point-of-care test for the determination of NT-proBNP in whole blood was developed based on the existing gold-label rapid immunoassay technology of the Roche Cardiac reader system. The novel gold-labelled monoclonal antibody recognizes NT-proBNP at amino acid sequence 27 to 31, the biotinylated polyclonal antibody recognizes sequence 39 to 50. In a model assay based upon the reference method Elecsys proBNP and with an R & D lot of the point-of-care test, this newly selected and developed combination of antibodies showed a very good correlation with the standard Elecsys proBNP assay with correlations of 0.

Translocation of alkali metal cations by lipophilic cyclodextrin derivatives through black lipid membranes.

Lipophilic cyclodextrin (CD) derivatives, synthetic ionophores, were prepared to transport alkali metal cations across a black lipid membrane (BLM). The purpose of this study is to develop a new class of an artificial transportation system of alkali metal cations via bilayer lipid membranes, by using CD derivatives as a cation carrier. A lipophilic CD derivative incorporated into a BLM forms a complex with an alkali metal cation at one surface of the membrane.